Bovine seminal ribonuclease attached to nanoparticles made of polylactic acid kills leukemia and lymphoma cell lines in vitro

Citation
M. Michaelis et al., Bovine seminal ribonuclease attached to nanoparticles made of polylactic acid kills leukemia and lymphoma cell lines in vitro, ANTI-CANC D, 11(5), 2000, pp. 369-376
Citations number
28
Categorie Soggetti
Pharmacology,"Onconogenesis & Cancer Research
Journal title
ANTI-CANCER DRUGS
ISSN journal
09594973 → ACNP
Volume
11
Issue
5
Year of publication
2000
Pages
369 - 376
Database
ISI
SICI code
0959-4973(200006)11:5<369:BSRATN>2.0.ZU;2-M
Abstract
Bovine seminal ribonuclease (BS-RNase) is a protein with a number of biolog ical effects. It shows antitumoral, aspermatogenic, antiembryonic, immunosu ppressive and antiviral properties. The cytotoxic effects appear to be spec ific for tumor cells as non-malignant cells seem to be unaffected in vitro. Unfortunately, the in vivo application of BS-RNase so far was successful o nly when it was administered intratumorally. Therefore, the objective of th e present investigation was to improve the properties of BS-RNase by attach ment to nanoparticles made of polylactic acid (PLA-NP) using an adsorption method. This preparation was tested in vitro against leukemia (MOLT-4) and lymphoma (H9) cell lines sensitive and resistant to cytarabine. No differen ce between the nanoparticle preparation and pure BS-RNase was found in thes e tests, To examine the in vivo effects, the preparations were tested for t heir aspermatogenic and antiembryonal efficacy compared to the pure BS-RNas e as a rapid test for antitumoral activity. The aspermatogenic and antiembr yonal effects were enhanced by the nanoparticle preparation, Consequently, BS-RNase loaded adsorptively to PLA-NP holds promise for the in vivo use as an antitumoral agent. Further research will investigate the efficacy of th is preparations in an in vivo tumor model. [(C) 2000 Lippincott Williams & Wilkins.].